by Cancer Core Europe | Jan 22, 2024 | Meet the People Behind
CCE Phase 1 Platform Coordinator Sofie Boutkan is a Clinical Alliance Manager for the NKI’s Early Drug Development Team, and coordinator of Cancer Core Europe’s Phase 1 platform. She has a master’s degree in human Movement Sciences, and has been working at the...
by Cancer Core Europe | Jan 22, 2024 | Cancer Core Europe
We are thrilled to announce that Cancer Core Europe has a new website. This transformation was driven by our commitment to enhancing CCE’s communication channels and effectively showcasing the remarkable work, events and activities, the dedicated individuals...
by Cancer Core Europe | Dec 21, 2023 | Cancer Core Europe, Cancer Core Europe Team
The Board of Directors of Cancer Core Europe recently approved the appointment of a Chief Scientific Officer (CSO) to the Consortium’s leadership team, designating Javier Carmona from the Vall d’Hebron Institute of Oncology (VHIO) to this new role, effective November...
by Cancer Core Europe | Dec 20, 2023 | Cancer Core Europe
As we enter the holiday season and look forward to the arrival of 2024, we extend our heartfelt greetings to each and every one of you for wonderful holidays spent with your loved ones and a happy New Year. I am optimistic that 2024 will bring exciting opportunities...
by Cancer Core Europe | Dec 18, 2023 | Cancer Core Europe, Education & Training
At Cancer Core Europe, we closed the 2023 Lecture Series with a remarkable intervention from Suzette Delaloge with her talk, “Towards Building Risk-Based Cancer Interception”. The virtual lecture was led by Gustave Roussy in collaboration with CCE’s Early Detection...
